Market Trends Candel initiated at buy by Citi, lead immunotherapy drugs citedBy admin8996erT0allFebruary 7, 2025 peterschreiber.mediaBofA has initiated coverage of Candel Therapeutics (NASDAQ:CADL) with a buy rating, citing the potential of its immunotherapy drug candidates…
